Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS
· Delayed Price · Currency is USD
0.0072
0.00 (0.00%)
At close: Apr 29, 2026
Petros Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Revenue | - | - | 5.82 | 5.99 | 7.81 | Upgrade
|
| Revenue Growth (YoY) | - | - | -2.83% | -23.29% | -18.29% | Upgrade
|
| Cost of Revenue | - | - | 1.63 | 2.29 | 1.6 | Upgrade
|
| Gross Profit | - | - | 4.19 | 3.7 | 6.21 | Upgrade
|
| Selling, General & Admin | 4.64 | 4.63 | 9.26 | 12.21 | 15.59 | Upgrade
|
| Research & Development | - | - | 2.41 | 1.74 | 1.79 | Upgrade
|
| Operating Expenses | 4.64 | 4.63 | 14.95 | 19.55 | 24.26 | Upgrade
|
| Operating Income | -4.64 | -4.63 | -10.76 | -15.85 | -18.05 | Upgrade
|
| Interest Expense | - | - | -0.54 | -0.6 | -0.37 | Upgrade
|
| Interest & Investment Income | 0.26 | 0.37 | 0.52 | 0.01 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.12 | 3.55 | 2.62 | 0.46 | - | Upgrade
|
| EBT Excluding Unusual Items | -4.5 | -0.71 | -8.16 | -15.97 | -18.42 | Upgrade
|
| Asset Writedown | - | - | - | -7.46 | - | Upgrade
|
| Other Unusual Items | - | - | - | 3.39 | 9.43 | Upgrade
|
| Pretax Income | -4.5 | -0.71 | -8.16 | -20.04 | -8.99 | Upgrade
|
| Earnings From Continuing Operations | -4.5 | -0.71 | -8.16 | -20.04 | -8.99 | Upgrade
|
| Earnings From Discontinued Operations | 6.41 | -13.61 | - | - | - | Upgrade
|
| Net Income | 1.91 | -14.32 | -8.16 | -20.04 | -8.99 | Upgrade
|
| Preferred Dividends & Other Adjustments | 45.6 | 12.48 | 5.65 | - | - | Upgrade
|
| Net Income to Common | -43.69 | -26.8 | -13.81 | -20.04 | -8.99 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 8641.96% | 268.84% | 5.11% | 90.11% | 103.90% | Upgrade
|
| EPS (Basic) | -1.56 | -83.47 | -158.71 | -241.98 | -206.31 | Upgrade
|
| EPS (Diluted) | -1.56 | -83.47 | -158.71 | -241.98 | -206.31 | Upgrade
|
| Free Cash Flow | -6.73 | -2.6 | -7.63 | -12.8 | -11.86 | Upgrade
|
| Free Cash Flow Per Share | -0.24 | -8.11 | -87.62 | -154.54 | -272.32 | Upgrade
|
| Gross Margin | - | - | 71.98% | 61.79% | 79.52% | Upgrade
|
| Operating Margin | - | - | -184.84% | -264.44% | -231.05% | Upgrade
|
| Profit Margin | - | - | -237.26% | -334.40% | -115.05% | Upgrade
|
| Free Cash Flow Margin | - | - | -130.99% | -213.57% | -151.86% | Upgrade
|
| EBITDA | -1.81 | -1.8 | -7.48 | -10.25 | -11.17 | Upgrade
|
| EBITDA Margin | - | - | -128.46% | -171.01% | -143.00% | Upgrade
|
| D&A For EBITDA | 2.83 | 2.83 | 3.28 | 5.6 | 6.88 | Upgrade
|
| EBIT | -4.64 | -4.63 | -10.76 | -15.85 | -18.05 | Upgrade
|
| EBIT Margin | - | - | -184.84% | -264.44% | -231.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.